Advisor Group Holdings, Inc. Hookipa Pharma Inc. Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.59 - $1.04 $88 - $156	150 Added 3.75%	4,150 $2,000
Q4 2023 Feb 12, 2024	BUY	$0.42 - $0.86 $1,680 - $3,440	4,000 New	4,000 $3,000
Q1 2023 May 12, 2023	BUY	$0.72 - $1.03 $532 - $762	740 Added 58.41%	2,007 $1,000
Q4 2022 Feb 10, 2023	BUY	$0.73 - $14.6 $815 - $16,308	1,117 Added 744.67%	1,267 $1,000
Q2 2022 Aug 10, 2022	SELL	$1.33 - $2.31 $532 - $924	-400 Reduced 72.73%	150 $0
Q1 2022 May 04, 2022	BUY	$1.26 - $2.52 $189 - $378	150 Added 37.5%	550 $1,000
Q1 2021 May 13, 2021	BUY	$10.64 - $14.7 $4,256 - $5,880	400 New	400 $5,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.